Mechanisms for oxidizing low-density lipoprotein: Insights from patterns of oxidation products in the artery wall and from mouse models of atherosclerosis

Trends in Cardiovascular Medicine

Volumn 11, Issue 3-4, 2001, Pages 103-112

  Gaut, Joseph P ^a   Heinecke, Jay W ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Box 8046   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; COLONY STIMULATING FACTOR 1; COPPER; HOMOCYSTEINE; IRON; LIPOXYGENASE; METAL ION; NITRIC OXIDE SYNTHASE; OXIDIZED LOW DENSITY LIPOPROTEIN; SUPEROXIDE; VERY LOW DENSITY LIPOPROTEIN;

ARTERY WALL; ATHEROGENESIS; ATHEROSCLEROSIS; CHEMICAL ANALYSIS; CHEMICAL MODIFICATION; CLINICAL TRIAL; DISEASE MODEL; GENETIC ENGINEERING; HUMAN; HYPOTHESIS; LIPID PEROXIDATION; LIPOPROTEIN METABOLISM; MACROPHAGE; MONOCYTE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; REVIEW;

EID: 0035181940     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1050-1738(01)00101-3     Document Type: Review

References (125)

1. Severe impairment in early host defense against Candida albicans in mice deficient in myeloperoxidase
2. Iron overload augments the development of atherosclerotic lesions in rabbits
3. Are body iron stores related to the risk of coronary heart disease?
4. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide
5. Oxidative chemistry of peroxynitrite
6. Oxygenation of lipoproteins by mammalian lipoxygenases
7. Enhanced levels of lipoperoxides in low density lipoprotein incubated with murine fibroblast expressing high levels of human 15-lipoxygenase
8. The role of oxidized lipoproteins in atherogenesis
9. Increased atherosclerosis in myeloperoxidase-deficient mice
10. Mouse models of atherosclerosis
11. A receptor-mediated pathway for cholesterol homeostasis
12. Nitrogen dioxide radical generated by the myeloperoxidase-hydrogen peroxide-nitrite system promotes lipid peroxidation of low density lipoprotein
13. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: Evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit
14. Superoxide anion participation in human monocyte-mediated oxidation of low-density lipoprotein and conversion of low-density lipoprotein to a cytotoxin
15. Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice
16. Effect of iron overload and iron deficiency on atherosclerosis in the hypercholesterolemic rabbit
17. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions
18. Isolation of low density lipoprotein from atherosclerotic vascular tissue of Watanabe heritable hyperlipidemic rabbits
19. Antioxidants and atherosclerotic heart disease
20. Intact human ceruloplasmin oxidatively modifies low density lipoprotein
21. Formation of nitrating and chlorinating species by reaction of nitrite with hypochlorous acid. A novel mechanism for nitric oxide-mediated protein modification
22. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils
23. The role of lipid peroxidation and antioxidants in oxidative modification of LDL
24. Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages
25. Lipoxygenase contributes to the oxidation of lipids in human atherosclerotic plaques
26. Oxidative tyrosylation of high density lipoprotein by peroxidase enhances cholesterol removal from cultured fibroblasts and macrophage foam cells
27. A comparison of the antiatherogenic effects of probucol and of a structural analogue of probucol in low density lipoprotein receptor-deficient rabbits
28. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Provenzione trial
29. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition
30. Peroxynitrite modification of low-density lipoprotein leads to recognition by the macrophage scavenger receptor
31. Human (THP-1) macrophages oxidize LDL by a thiol-dependent mechanism
32. Redox control of vascular smooth muscle proliferation
33. Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits
34. Endothelial function and oxidant stress
35. Studies on the chlorinating activity of myeloperoxidase
36. Action of nitric oxide as an antioxidant against oxidation of soybean phosphatidylcholine liposomal membranes
37. 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima
38. Human neutrophils employ chlorine gas as an oxidant during phagocytosis
39. Vitamin E supplementation and cardiovascular events in high-risk patients
40. Oxidants and antioxidants in the pathogenesis of atherosclerosis: Implications for the oxidized low density lipoprotein hypothesis
41. Is lipid peroxidation relevant to atherogenesis?
42. Mass spectrometric quantification of amino acid oxidation products in proteins: Insights into pathways that promote LDL oxidation in the human artery wall
43. Superoxide-mediated modification of low density lipoprotein by arterial smooth muscle cells
44. Detecting oxidative modification of biomolecules with isotope dilution mass spectrometry: Sensitive and quantitative assays for oxidized amino acids in proteins and tissues
45. Oxidation of low density lipoprotein by thiols: Superoxide-dependent and -independent mechanisms
46. Dityrosine, a specific marker of oxidation, is synthesized by the myeloperoxidase-hydrogen peroxide system of human neutrophils and macrophages
47. Tyrosyl radical generated by myeloperoxidase catalyzes the oxidative cross-linking of proteins
48. Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture
49. The role of sulfur-containing amino acids in superoxide production and modification of low density lipoprotein by arterial smooth muscle cells
50. p-Hydroxyphenylacetaldehyde, an aldehyde generated by myeloperoxidase, modifies phospholipid amino groups of low density lipoprotein in human atherosclerotic intima
51. Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: Recognition by receptors for acetylated low density lipoproteins
52. Inhibition of low-density lipoprotein oxidation by nitric oxide. Potential role in atherogenesis
53. Vascular effects following homozygous disruption of p47(phox): An essential component of NADPH oxidase
54. Formation of o-tyrosine and dityrosine in proteins during radiolytic and metal-catalyzed oxidation
55. Leukocyte oxygen activation and microbicidal oxidative toxins
56. Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice
57. The p47phox mouse knock-out model of chronic granulomatous disease
58. The participation of nitric oxide in cell free- and its restriction of macrophage-mediated oxidation of low-density lipoprotein
59. Studies on iron dextran complexes
60. Nonenzymatic cleavage of proteins by reactive oxygen species generated by dithiothreitol and iron
61. Impaired superoxide production due to a deficiency in phagocyte NADPH oxidase fails to inhibit atherosclerosis in mice
62. Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia
63. Oxygen metabolism and the toxic properties of phagocytes
64. In vivo action of 15-lipoxygenase in early stages of human atherogenesis
65. Transition metal ions within human atherosclerotic lesions can catalyse the oxidation of low density lipoprotein by macrophages
66. Reactive nitrogen intermediates promote low density lipoprotein oxidation in human atherosclerotic intima
67. Mass spectrometric quantification of markers for protein oxidation by tyrosyl radical, copper, and hydroxyl radical in low density lipoprotein isolated from human atherosclerotic plaques
68. Physiological thiol compounds exert pro- and anti-oxidant effects, respectively, on iron- and copper-dependent oxidation of human low-density lipoproteins
69. Electron paramagnetic resonance detection of free tyrosyl radical generated by myeloperoxidase, lactoperoxidase, and horseradish peroxidase
70. Glutathione metabolism and its selective modification
71. Hemochromatosis, multiorgan hemosiderosis, and coronary artery disease
72. Generation of superoxide free radical during the autoxidation of thiols
73. Nitric oxide: Physiology, pathophysiology, and pharmacology
74. Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation
75. The isoprostanes. Current knowledge and directions for future research
76. Identification of the prooxidant site of human ceruloplasmin: A model for oxidative damage by copper bound to protein surfaces
77. Effect of iron dextran on atherogenesis in cholesterol and corn oil fed rabbits
78. Immunohistochemical and genetic evidence of myeloperoxidase involvement in multiple sclerosis
79. Coexistence of oxidized lipids and alpha-tocopherol in all lipoprotein density fractions isolated from advanced human atherosclerotic plaques
80. Oxidation of low-density lipoprotein by thiol compounds leads to its recognition by the acetyl LDL receptor
81. A role for endothelial cell lipoxygenase in the oxidative modification of low density lipoprotein
82. Isoprostanes: Potential markers of oxidant stress in atherothrombotic disease
83. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells
84. Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro
85. Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production
86. Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in ApoE-deficient mice
87. Heterozygous osteopetrotic (op) mutation reduces atherosclerosis in LDL receptor-deficient mice
88. Myeloperoxidase polymorphism is associated with gender specific risk for Alzheimer's disease
89. Distribution of oxidation specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits
90. Superoxide-dependent formation of hydroxyl radicals in the presence of thiol compounds
91. Nitric oxide inhibition of lipoxygenase-dependent liposome and low-density lipoprotein oxidation: Termination of radical chain propagation reactions and formation of nitrogen-containing oxidized lipid derivatives
92. Tyrosyl radical generated by myeloperoxidase is a physiological catalyst for the initiation of lipid peroxidation in low density lipoprotein
93. Oxidation of polyunsaturated fatty acids and lipids through thiyl and sulfonyl radicals: Reaction kinetics, and influence of oxygen and structure of thiyl radicals
94. Macrophage-mediated 15-lipoxygenase expression protects against athersclerosis development
95. Fibroblasts that overexpress 15-lipoxygenase generate bioactive and minimally modified LDL
96. Stimulation of lipid peroxidation and hydroxyl-radical generation by the contents of human atherosclerotic lesions
97. Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E
98. Cellular oxidation of low density lipoprotein is caused by thiol production in media containing transition metal ions
99. Enzymatic modification of low density lipoprotein by purified lipoxygenase plus phospholipase A2 mimics cell-mediated oxidative modification
100. Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine
101. Clinical trials on antioxidants in atherosclerosis: Are we doing the right thing?
102. Role of superoxide in endothelial-cell modification of low-density lipoproteins
103. Recognition of oxidized low density lipoprotein by the scavenger receptor of macrophages results from derivatization of apolipoprotein B by-products of fatty acid peroxidation
104. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density liproprotein phospholipids
105. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS)
106. The ambivalence of vitamin E in atherogenesis
107. Prooxidant iron and copper, with ferroxidase and xanthine oxidase activities in human atherosclerotic material
108. Thiol-dependent lipid peroxidation
109. Fatty streak formation in fat-fed mice expressing human copper-zinc superoxide dismutase
110. Enhanced in vivo lipid peroxidation at elevated plasma total homocysteine levels
111. Brominating oxidants generated by human eosinophils
112. Homocysteine and atherothrombosis
113. Dissociation of atherogenesis from aortic accumulation of lipid hydro(pero)xides in Watanabe heritable hyperlipidemic rabbits
114. Role of oxidized low density lipoprotein in atherogenesis
115. Structural requirements for oxidation of low density lipoprotein by thiols
116. The role of thiols in oxidation of low-density lipoprotein by macrophages
117. Mammalian lipoxygenases: Molecular structures and functions
118. A protective role for nitric oxide in the oxidative modification of low density lipoproteins by mouse macrophages
119. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man
120. Colocalization of 15-lipoxygenase messenger RNA and protein with epitopes of oxidized low density lipoprotein in macrophage-rich areas of atherosclerotic lesions
121. Paradoxical enhancement of atherosclerosis by probucol treatment in apolipoprotein E-deficient mice
122. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E